Second and Third Generational Advances in Therapies of the Immune-Mediated Kidney Diseases in Children and Adolescents
Therapy of immune-mediated kidney diseases has evolved during recent decades from the non-specific use of corticosteroids and antiproliferative agents (like cyclophosphamide or azathioprine), towards the use of more specific drugs with measurable pharmacokinetics, like calcineurin inhibitors (cyclos...
Saved in:
Main Authors: | Ryszard Grenda (Author), Łukasz Obrycki (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of the Second and Third-Generation of DNA Sequencing Technologies
by: Fatemeh Ghorbani Parsa, et al.
Published: (2017) -
Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis
by: Prashant P. Mande, et al.
Published: (2017) -
Second-generation antipsychotic and diabetes mellitus in children and adolescents
by: Carlo Ripoli, et al.
Published: (2017) -
Editorial: Optimizing outcomes for children with immune-mediated chronic kidney disease
by: Thomas Renson, et al.
Published: (2024) -
Anxiety in Children and Adolescents with Chronic Kidney Disease - Multicenter National Study Results
by: Katarzyna Kiliś-Pstrusińska, et al.
Published: (2013)